Medrio vs. Zelta

Overview
ProductRatingMost Used ByProduct SummaryStarting Price
Medrio
Score 4.6 out of 10
N/A
Medrio offers solutions and support to pharmaceuticals, biotech, medical devices, and diagnostics, ensuring quality data capture and optimized workflows with CDMS/EDC, eCOA/ePRO, eConsent, and RTSM solutions.N/A
Zelta
Score 8.0 out of 10
N/A
Zelta is a cloud-based unified clinical data management and acquisition platform with customizable modules, that can be tailored to the meet the needs of clinical trials and accelerate outcomes.N/A
Pricing
MedrioZelta
Editions & Modules
No answers on this topic
No answers on this topic
Offerings
Pricing Offerings
MedrioZelta
Free Trial
NoNo
Free/Freemium Version
NoNo
Premium Consulting/Integration Services
NoNo
Entry-level Setup FeeNo setup feeOptional
Additional DetailsSubscription - For larger organizations and those who need a predictable budget. Most modules included without incurring additional fees. Eligible for volume discounts. Pay per use - For organizations that need flexibility without a long term contractual commitment. Transparent a la carte pricing, no minimums. Fees start when trial goes live.
More Pricing Information
Community Pulse
MedrioZelta
Considered Both Products
Medrio

No answer on this topic

Zelta
Chose Zelta
It was easier to understand the usability of the software [Zelta]. For our engineers [it] was easier to migrate our data, and fully set up everything. We found out that comparing other software[s], this one is safe, easy to use, has more functionalities, [and it's] easier to …
Chose Zelta
IBM Clinical Trail offers an improvement on the above as it is considerably easier to navigate and has many more features. The side did seem faster however and could be used via an app which is useful in a busy environment. Both are around the same price bracket give or take.
Chose Zelta
Zelta is as good or better than Rave. I believe that Zelta has a more friendly user interface and is easier to navigate on the designer and Site side. CRF build and study build in general appears to be easier and Zelta can be used for almost any kind of clinical study that Rave …
Chose Zelta
I have used Clindex, Oracle Clinical, MediData, and MS Access for clinical trials. The product I had the most success with was Clindex but Zelta was a close second. I did not select Zelta as it was being used when I joined the company. I became a developer within a few months …
Chose Zelta
Zelta by Merative supersedes the Medrio EDC at any given point of time and on all evaluation criteria. Also as compared to Medidata Rave EDC, database programming is easier due to its intuitive GUI; someone with little or absolutely no knowledge of any programming language can …
Chose Zelta
Zelta by Merative supersedes the Medrio EDC at any given point of time and on all evaluation criteria. Also as compared to Medidata RAVE EDC, database programming is easier due to its intuitive GUI and someone with little or absolutely no knowledge of any programming language …
Chose Zelta
Similar database use is mainly study specific.
Chose Zelta
Zelta system runs faster, easier to use.
Chose Zelta
Zelta is a fast database, doesn't cause waiting during the data entry or when saving the data. This is mostly appreciated by the site staff as they have limited time and any delay is crucial for them. Zelta has an unlimited option for edit checks that helps collect accurate …
Chose Zelta
I haven't got an opportunity to evaluate any products.
Chose Zelta
Zelta has an easier set-up, maintenance and modifiability. Also, there is a cost saving when using Zelta by Merative for a study as Medidata is very expensive.
Chose Zelta
More flexibility with Zelta, less heavy to design and offer[s] strong feature[s]. Rave is a stronger EDC system with a very interesting reporting option and a very good reputation with the users, however very heavy to manipulate from the design side.
Chose Zelta
Electronic data management system which is Abbott owned system. The system cannot be currently used outside of Abbott.
Chose Zelta
The selection was made by previous stakeholders based on Zelta suitability to handle medical device data and costs.
User Ratings
MedrioZelta
Likelihood to Recommend
10.0
(0 ratings)
8.0
(0 ratings)
Likelihood to Renew
-
(0 ratings)
9.1
(0 ratings)
Usability
-
(0 ratings)
8.0
(0 ratings)
Availability
-
(0 ratings)
8.2
(0 ratings)
Performance
-
(0 ratings)
7.3
(0 ratings)
Support Rating
10.0
(0 ratings)
9.0
(0 ratings)
Implementation Rating
-
(0 ratings)
8.2
(0 ratings)
Configurability
-
(0 ratings)
8.2
(0 ratings)
Ease of integration
-
(0 ratings)
7.3
(0 ratings)
Product Scalability
-
(0 ratings)
7.3
(0 ratings)
Vendor post-sale
-
(0 ratings)
7.3
(0 ratings)
Vendor pre-sale
-
(0 ratings)
7.3
(0 ratings)
User Testimonials
MedrioZelta
Likelihood to Recommend
Medrio is very user friendly and even allows the user to print out the eCRFs to be used as source documents. This makes creating source documents very easy for the Research team and the information directly matches the EDC, which makes the monitoring process go much smoother. The process for withdrawing a subject can be a bit confusing, as the system only allows for a "screen-failure" designation and not an option for withdrawal, or is lost to follow-up.
Read full review
Zelta is a good tool for companies currently utilizing multiple software platforms to create and monitor clinical trial information. Due to the price, it is best suited for large pharmaceutical manufacturers with active pipelines and high R&D spend. Zelta's value is more limited to smaller, more focused companies.
Read full review
Pros
  • Ease of navigation for entering subject data.
  • Very organized placement of eCRFs.
  • Allows for accurate and efficient data collection.
Read full review
  • It is highly customizable and easy to program.
  • There is a wide variety of data that can be collected from IRB/site information to clinical data.
  • Zelta provides comprehensive edit language to program for accurate results.
  • Page dynamics are very useful when including or hiding certain data questions.
Read full review
Cons
  • The system does not allow a separate designation for screen failures that were lost to follow-up or who were withdrawn by the PI.
  • When a subject is deemed a screen-failure, eCRFs are still expected to be filled out and it is unclear which ones unless otherwise directed by the in-house team.
Read full review
  • Would like to have more access to report review. Most of the functions are controlled by the initial data management setup of the specific reports. I would like to be able to run my own custom programs as a CRA (some way to bypass internal programming).
  • Sites note that they are limited in pulling tables (with specific information ) based on internal programming. I only see what DM has allowed with the CVS/EXCEL tables.
  • Better user guide to assist with training.
Read full review
Likelihood to Renew
No answers on this topic
We are satisfied from our experience with Zelta by Merative, the close collaboration we have with the Zelta team is also something we value. We plan to use Zelta for a long time
Read full review
Usability
No answers on this topic
It is easy to use, it helps us to be more productive, work better with teams anywhere they are, especially during the pandemic it was really helpful, it is easier to find data, to organize data, improving our findings, reducing time significantly, and more importantly been able to help in better ways our patients.
Read full review
Reliability and Availability
No answers on this topic
available when needed
Read full review
Performance
No answers on this topic
some audit reports are difficult to download and take time subject pdf also takes some time to download
Read full review
Support Rating
I have not had any technical issues with this product in the two years I've used it, which speaks for itself. I like how I am now able to use my email address to sign in instead of remembering yet another user name, this makes using this EDC a much more enjoyable experience.
Read full review
Our organization has been using both Zelta and in-house applications. The main considerations on which one to use for a particular study is time to get the databases running, cost, and ease of use. For some studies, the time and cost of using Zelta are negative factors, and an in-house system is selected.
Read full review
Online Training
No answers on this topic
very efficient self training
Read full review
Implementation Rating
No answers on this topic
again not sure about it, I wasn't part of our organization yet
Read full review
Alternatives Considered
No answers on this topic
Zelta is as good or better than Rave. I believe that Zelta has a more friendly user interface and is easier to navigate on the designer and Site side. CRF build and study build in general appears to be easier and Zelta can be used for almost any kind of clinical study that Rave can be used for.
Read full review
Return on Investment
  • Monitoring visits run much smoother due to the fact that eCRFs can be directly printed from the EDC.
  • Information requested in the EDC is clear and concise and easy to understand.
Read full review
  • Time Saving - We could deliver a fully functional eCRF within the record time of 15 days.
  • Cost Saving - Reduces the overall turn around time thus eventually helping stay within the budget.
  • Prompt customer support team thus helping in before time resolution of issues.
Read full review
ScreenShots

Zelta Screenshots

Screenshot of the ePRO DiaryScreenshot of Local LabsScreenshot of Medical Coding with AIScreenshot of Site user data entryScreenshot of the Study Connect DashboardScreenshot of the Study Designer Logic Editor